Literature DB >> 30369002

Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes.

Rajab Idriss1, Jeanette Hasse1, Tiffany Wu2, Fatima Khan1, Giovanna Saracino1, Greg McKenna1, Giuliano Testa1, James Trotter1, Goran Klintmalm1, Sumeet K Asrani1.   

Abstract

Bariatric surgery (BS) is effective in treating morbid obesity, but the impact of prior BS on candidacy for liver transplantation (LT) is unclear. We examined 78 patients with cirrhosis with prior BS compared with a concurrent cohort of 156 patients matched by age, Model for End-Stage Liver Disease score, and underlying liver disease. We compared rates of transplant denial after evaluation, delisting on the waiting list, and survival after LT. The median time from BS to LT evaluation was 7 years. Roux-en-Y gastric bypass was the most common BS procedure performed (63% of cohort). Nonalcoholic fatty liver disease was the leading etiology for liver cirrhosis (47%). Delisting/death on the waiting list was higher among patients with BS (33.3% versus 10.1%; P = 0.002), and the transplantation rate was lower (48.9% versus 65.2%; P = 0.03). Intention-to-treat (ITT) survival from listing to 1 year after LT was lower in the BS cohort versus concurrent cohort (1-year survival, 84% versus 90%; P = 0.05). On adjusted analysis, a history of BS was associated with an increased risk of death on the waiting list (hazard ratio [HR], 5.7; 95% confidence interval [CI], 2.2-15.1), but this impact was attenuated (HR, 4.9; 95% CI, 1.8-13.4) by the presence of malnutrition. When limited to matched controls by sex, mortality attributed to BS was no longer significant for females (P = 0.37) but was significant for males (P = 0.046). Sarcopenia, as captured by skeletal muscle index, was calculated in a subset of patients (n = 49). The total skeletal surface area was lower in the BS group (127 [105-141] cm2 versus 153 [131-191] cm2 ; P = 0.005). Rates of sarcopenia were higher among patients delisted after listing (71.4% versus 16.7%; P = 0.04). In conclusion, a history of BS was associated with higher rates of delisting on the waiting list as well as lower survival from the time of listing on ITT analysis. Presence of malnutrition and sarcopenia among patients with BS may contribute to worse outcomes.
Copyright © 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2019        PMID: 30369002     DOI: 10.1002/lt.25368

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

1.  Laparoscopic Revisional Conversion of Sleeve Gastrectomy to Gastric Bypass After Liver Transplantation.

Authors:  Sergio Riveros; Martín Inzunza; Fernando Crovari; Eduardo Briceño; Pablo Achurra; Nicolás Quezada
Journal:  Obes Surg       Date:  2021-01-08       Impact factor: 4.129

Review 2.  Bariatric Surgery in the Peritransplant Period.

Authors:  Sydney Pomenti; Sanket Mehta; Averill Guo; Julia Wattacheril
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

3.  Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences?

Authors:  Suzanne R Sharpton; Norah A Terrault
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

4.  Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis.

Authors:  Víctor Lopez-Lopez; Juan José Ruiz-Manzanera; Dilmurodjon Eshmuminov; Kuno Lehmann; Marcel Schneider; Markus von der Groeben; David Ruiz de Angulo; Ursula Gajownik; Jose Antonio Pons; Francisco Sánchez-Bueno; Ricardo Robles-Campos; Pablo Ramírez-Romero
Journal:  Obes Surg       Date:  2020-11-23       Impact factor: 4.129

Review 5.  Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.

Authors:  Anchalia Chandrakumaran; Mohammad Shadab Siddiqui
Journal:  Gastroenterol Clin North Am       Date:  2020-03       Impact factor: 3.806

Review 6.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 7.  Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

Authors:  Naga Swetha Samji; Rajiv Heda; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

8.  Bariatric Surgery in Cirrhotic Patients: a Matched Case-Control Study.

Authors:  Nicolás Quezada; Gregorio Maturana; María Jesús Irarrázaval; Rodrigo Muñoz; Sebastián Morales; Pablo Achurra; Cristóbal Azócar; Fernando Crovari
Journal:  Obes Surg       Date:  2020-08-17       Impact factor: 4.129

Review 9.  AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.

Authors:  Heather Patton; Julie Heimbach; Arthur McCullough
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 11.382

Review 10.  Obesity in the Liver Transplant Setting.

Authors:  Carlos Moctezuma-Velazquez; Ernesto Márquez-Guillén; Aldo Torre
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.